Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00002767
What this trial is testing

Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
GlaxoSmithKline 300
Testing effectiveness (Phase 2)Ended earlyNCT00610311
What this trial is testing

Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Ended earlyNCT01995344
What this trial is testing

TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment

Who this might be right for
Metastatic Melanoma
The Christie NHS Foundation Trust 2
Testing effectiveness (Phase 2)Study completedNCT00244816
What this trial is testing

Taxoprexin® Treatment for Advanced Eye Melanoma

Who this might be right for
Metastatic Melanoma
American Regent, Inc. 22
Early research (Phase 1)Study completedNCT00527657
What this trial is testing

Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients

Who this might be right for
Brain NeoplasmsMelanoma
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)WithdrawnNCT05299580
What this trial is testing

"Dabrafenib and Trametinib in Circulating Free DNA BRAFV600 Mutated Metastatic Melanoma Patients: a Prospective Phase II, Open Label, Multicentre Study - (Bioliquid TAILOR Study - BIOTAILOR)"

Who this might be right for
Melanoma
Fondazione Melanoma Onlus
Testing effectiveness (Phase 2)Active Not RecruitingNCT07288203
What this trial is testing

Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

Who this might be right for
Melanoma (Skin Cancer)Unresectable MelanomaMetastatic Melanoma
Iovance Biotherapeutics, Inc. 100
Early research (Phase 1)Study completedNCT00091689
What this trial is testing

Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions

Who this might be right for
Melanoma
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00281541
What this trial is testing

The Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

Who this might be right for
Melanoma
Astellas Pharma Inc 29
Testing effectiveness (Phase 2)Study completedNCT00099970
What this trial is testing

Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy

Who this might be right for
MelanomaMetastases
PDL BioPharma, Inc. 40
Large-scale testing (Phase 3)UnknownNCT05647954
What this trial is testing

HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver

Who this might be right for
Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
Taizhou Hanzhong biomedical co. LTD 350
Testing effectiveness (Phase 2)Looking for participantsNCT06359860
What this trial is testing

ST-1898 for Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Beijing Scitech-Mq Pharmaceuticals Limited 64
Large-scale testing (Phase 3)Study completedNCT01721746
What this trial is testing

Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

Who this might be right for
Unresectable or Metastatic Melanoma
Bristol-Myers Squibb 405
Testing effectiveness (Phase 2)Study completedNCT02085070
What this trial is testing

MK-3475 in Melanoma and NSCLC Patients With Brain Metastases

Who this might be right for
MelanomaNon-Small Cell Lung CancerBrain Metastases
Yale University 65
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Early research (Phase 1)Study completedNCT00005057
What this trial is testing

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
National Human Genome Research Institute (NHGRI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04139902
What this trial is testing

Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Diwakar Davar 48
Not applicableStudy completedNCT03325257
What this trial is testing

Post-ATU Study of Nivolumab

Who this might be right for
Melanoma
Nantes University Hospital 350
Testing effectiveness (Phase 2)Ended earlyNCT01988077
What this trial is testing

Clinical Evaluation of Yervoy in Combination With Adoptive T Cell Transfer for Metastatic Melanoma Patients

Who this might be right for
A Combination of Adoptive T Cell Therapy and Ipilimumab Could Increase the Proportion of CR Patients, and Durability of Response
Sheba Medical Center 2
Large-scale testing (Phase 3)Study completedNCT00094653
What this trial is testing

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

Who this might be right for
MelanomaMetastases
Bristol-Myers Squibb 1,783
Next Page